USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Abbott Rapid Diagnostics International Unlimited Company

USPTO PatentsView assignee record - 8 granted patents across 9 technology areas, active 2020–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

7.0

Avg claims per patent

5-year filing velocity

The verdict

Abbott holds 8 US patents across 9 technology areas, rank #30,840 of 50,000 tracked assignees.

#30,840
of 50,000 US assignees by volume: Top 31%
by Innovation Score (42.4/100): 7.0
avg claims per patent

Portfolio overview

Abbott Rapid Diagnostics International Unlimited Company has been granted 8 US utility patents between 2020 and 2024, placing Abbott Rapid Diagnostics International Unlimited Company at rank #30,840 across all assignees tracked by PlainPatent. This portfolio spans 9 distinct Cooperative Patent Classification (CPC) subclasses, averaging 7.0 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a Foreign Corporation, Abbott Rapid Diagnostics International Unlimited Company is one of the more focused assignees in the PatentsView dataset. By volume, Abbott sits between Axtuator OY (8 patents, rank #30,836) and Accesso Technology Group Plc (8 patents, rank #30,844) - the closest US assignees by grant volume. The composite Innovation Score of 42.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2020 through 2024, with 8 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Abbott Rapid Diagnostics International Unlimited Company's 7.0 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 9 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Abbott Rapid Diagnostics International Unlimited Company against peers pursuing similar technology classes.

Axtuator OY

8
Azoteq (PTY)

8
Azure Vault

8
Aavid Thermal

8
Abilene Christian…

8
Accelerate Labs

8
Accentus Medical

8
Accesso Technolog…

8
Abbott Rapid Diag… ◀

8

What this shows Abbott holds 8 patents at rank #30,840, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Abbott

By rank, the assignees closest to #30,840 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Abbott's primary technology class.

Abbott's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

42 Top 31% higher than 69% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Abbott Rapid Diagnostics International Unlimited Company patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	12.5%
2021	1	12.5%
2022	2	25.0%
2023	2	25.0%
2024	2	25.0%

Which technologies does Abbott Rapid Diagnostics International Unlimited Company patent most?

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 4

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 2

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 1

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 1

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 1

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 1

B65D - CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES 1

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 1

C07K - PEPTIDES 1

Top 9 of 9 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Simple

Where it ranks

Overall rank by patents

#30,840

Across all tracked assignees

Innovation Score

42.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Abbott Rapid Diagnostics International Unlimited Company hold?

Abbott Rapid Diagnostics International Unlimited Company holds 8 US granted patents filed between 2020 and 2024, spanning 9 technology areas.

What is Abbott Rapid Diagnostics International Unlimited Company's Innovation Score?

Abbott Rapid Diagnostics International Unlimited Company has an Innovation Score of 42.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Abbott Rapid Diagnostics International Unlimited Company focus on?

Abbott Rapid Diagnostics International Unlimited Company's top technology area is G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES) with 4 patents. The company has filed patents in 9 CPC subclasses total.

Is Abbott Rapid Diagnostics International Unlimited Company's patent filing rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Abbott Rapid Diagnostics International Unlimited Company.

What does claim depth mean for Abbott Rapid Diagnostics International Unlimited Company's patents?

Abbott Rapid Diagnostics International Unlimited Company's patents average 7.0 claims each. This is relatively simple claim structure, typical for focused inventions.

How is the Abbott Rapid Diagnostics International Unlimited Company patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Abbott's 8 grants land it in the top 31% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Abbott ranks #30,840 of 50,000. Top 50 holders
Most of this portfolio concentrates in G01N - see who else leads that technology area. G01N leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.